http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201831475-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 2017-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe18dc719f3ce6fa0e63089a6b1a7d12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f527204529c6c825729299114a5a0c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4b26aac6b2f5edba32e0a1ebc1047be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbed60a30fb16396fa399e8bd6b4bdb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddea1f8c0f801376d92fd1ad345aea17
publicationDate 2018-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-201831475-A
titleOfInvention Substituted pyrido[3,4-B]indole and its use as a medicament
abstract This application relates to 8-aryl-substituted and 8-heteroaryl-substituted 9H-pyrido [3,4-b] indoles of formula I, n n n Where A, E, G, R 1 to R 6 and R 10 are as defined in the claim, which stimulate chondrogenesis and cartilage matrix synthesis and can be used to treat cartilage disorders and conditions in which regeneration of damaged cartilage is desired, such as joint diseases Such as osteoarthritis. The present application also relates to methods for synthesizing compounds of formula I, their use as medicaments, and pharmaceutical compositions containing them.
priorityDate 2016-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466078925

Total number of triples: 30.